Effect of Bifidobacterium infantis on interferon-γ-induced keratinocyte apoptosis: A potential therapeutic approach to skin immune abnormalities

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 4, 2006, Pages 775-786

  Cinque, B ^a   Di Marzio, L ^b   Della Riccia, D N ^a   Bizzini, F ^a   Giuliani, M ^c   Fanini, D ^a   De Simone, C ^a   Cifone, M Grazia ^a,c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Apoptosis; Bifidobacterium infantis; HaCaT; T cell activation

Indexed keywords

BIFIDOBACTERIUM INFANTIS EXTRACT; FAS LIGAND; GAMMA INTERFERON; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; PHYTOHEMAGGLUTININ; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM LONGUM INFANTIS; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

EID: 33846412936     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900407     Document Type: Article

References (34)

1. Trautmann A., M. Akdis, D. Kleemann, F. Altznauer, H.U. Simon, T. Graeve, M. Noll, E.B. Brocker, K. Blaser and C.A. Akdis. 2000. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106:25.
2. + T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168:3079.
3. Cooper K.D. 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102:128.
4. Grewe M., C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka and J. Krutmann. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19:359.
5. Grewe M., K. Gyufko, E. Schopf and J. Krutmann. 1994. Lesional expression of interferon-gamma in atopic eczema. Lancet 343:25.
6. Ohmen J.D., J.M. Hanifin, B.J. Nickoloff, T.H. Rea, R. Wyzykowski, J. Kim, D. Jullien, T. McHugh, A.S. Nassif and S.C. Chan. 1995. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1956.
7. Hamid Q., T. Naseer, E.M. Minshall, Y.L. Song, M. Boguniewicz and D.Y. Leung. 1996. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy. Clin. Immunol. 98:225.
8. Spergel J.M., E. Mizoguchi, H. Oettgen, A.K. Bhan and R.S. Geha. 1999. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103:1103.
9. Barker J.N., M.H. Allen and D.M. MacDonald. 1990. Alterations induced in normal human skin by in vivo interferon-gamma. Br. J. Dermatol. 122:451.
10. Fuchs E. 1990. Epidermal differentiation: the bare essentials. J. Cell. Biol. 111:2807.
11. Leung D.Y. 1999. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 104:99.
12. Leung D.Y. 2000. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105:860.
13. Zaki I., R. Emerson and B.R. Allen. 1996. Treatment of severe atopic dermatitis in childhood with cyclosporin. Br. J. Dermatol. 135:21.
14. Zurbriggen B., B. Wuthrich, A.B. Cachelin, P.B. Wili and M.K. Kagi. 1999. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study. Dermatology 198:56.
15. Bekersky I., W. Fitzsimmons, A. Tanase, R.M. Maher, E. Hodosh and I. Lawrence. 2001. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J. Am. Acad. Dermatol. 44:17.
16. Erickson K.L. and N.E. Hubbard. 2000. Probiotic immunomodulation in health and disease. J. Nutr. 130:403.
17. Matsumoto S., N. Watanabe, A. Imaoka and Y. Okabe. 2001. Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Digestion 64:92.
18. Schultz M., H.J. Linde, N. Lehn, K. Zimmermann, J. Grossmann, W. Falk and J. Scholmerich. 2003. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res. 70:165.
19. Dugas B., A. Mercenier, I. Lenoir-Wijnkoop, C. Arnaud, N. Dugas and E. Postaire. 1999. Immunity and probiotics. Immunol. Today 20:387.
20. Gorbach S.L. 2000. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 95:2.
21. Perdigon G., S. Alvarez, M. Rachid, G. Aguero and N. Gobbato. 1995. Immune system stimulation by probiotics. J. Dairy Sci. 78:1597.
22. Watanabe T. 1996. Suppressive effects of Lactobacillus casei cells, a bacterial immunostimulant, on the incidence of spontaneous thymic lymphoma in AKR mice. Cancer Immunol. Immunother. 42:285.
23. Di Marzio L., F.P. Russo, S. D'Alo, L. Biordi, S. Ulisse, G. Amicosante, C. De Simone and M.G. Cifone. 2001. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr. Cancer 40:185.
24. Boukamp P., R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham and N.E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761.
25. Dave R.I. and N.P. Shah. 1996. Evaluation of media for selective enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and bifidobacteria. J. Dairy Sci. 79:1529.
26. Gonzalez R., A. Blancas, R. Santillana, A. Azaola and C. Wacher. 2004. Growth and final product formation by Bifidobacterium infantis in aerated fermentations. Appl. Microbiol. Biotechnol. 65:606.
27. Nicoletti I., G. Migliorati, M.C. Pagliacci, F. Grignani and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
28. Trautmann A., M. Akdis, P. Schmid-Grendelmeier, R. Disch, E.B. Brocker, K. Blaser and C.A. Akdis. 2001. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 108:839.
29. Sayama K., S. Yonehara, Y. Watanabe and Y. Miki. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330.
30. Matsue H., H. Kobayashi, T. Hosokawa, T. Akitaya and A. Ohkawara. 1995. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch. Dermatol. Res. 287:315.
31. Tamaki K. and K. Nakamura. 2001. The role of lymphocytes in healthy and eczematous skin. Curr. Opin. Allergy Clin. Immunol. 1:455.
32. Kalliomaki M., P. Kirjavainen, E. Eerola, P. Kero, S. Salminen and E. Isolauri. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:129.
33. Bjorksten B., E. Sepp, K. Julge, T. Voor and M. Mikelsaar. 2001. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108:516.
34. Watanabe S., Y. Narisawa, S. Arase, H. Okamatsu. T. Ikenaga, Y. Tajiri and M. Kumemura. 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 111:587.